Filing Details

Accession Number:
0001666071-21-000200
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-10-06 18:15:17
Reporting Period:
2021-10-04
Accepted Time:
2021-10-06 18:15:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1666071 Cardlytics Inc. CDLX () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1617486 D. Scott Grimes C/O Cardlytics, Inc.
675 Ponce De Leon Avenue Ne, Suite 6000
Atlanta GA 30308
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2021-10-04 804 $78.98 64,308 No 4 S Indirect See Footnote
Common Stock Disposition 2021-10-04 501 $80.00 63,807 No 4 S Indirect See Footnote
Common Stock Disposition 2021-10-04 138 $81.12 63,669 No 4 S Indirect See Footnote
Common Stock Disposition 2021-10-04 557 $82.04 63,112 No 4 S Indirect See Footnote
Common Stock Acquisiton 2021-10-06 39,375 $0.00 265,049 No 4 M Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 S Indirect See Footnote
No 4 M Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Performance Stock Unit Acquisiton 2021-10-06 78,750 $0.00 78,750 $0.00
Common Stock Performance Stock Unit Disposition 2021-10-06 39,375 $0.00 39,375 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
78,750 No 4 A Direct
39,375 No 4 M Direct
Footnotes
  1. These sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the trustee of the 2013 Scott Grimes GRAT UAD (the "GRAT") on November 15, 2019, as amended March 12, 2020.
  2. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $78.58 to $79.57, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (5) and (6) to this Form 4.
  3. The reportable securities are held by the GRAT.
  4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $79.58 to $80.52, inclusive.
  5. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $80.61 to $81.52, inclusive.
  6. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $81.65 to $82.53, inclusive.
  7. Represents the underlying vested shares of common stock of the Issuer which have not been delivered.
  8. Each performance stock unit ("PSU") represents a contingent right to receive one share of the Issuer's Common Stock.
  9. On October 6, 2021 the Compensation Committee of the Issuer's Board of Directors certified that a target minimum number of advertisers with a specified billings threshold over a trailing 12-month period was achieved (the "Certification") resulting in the award of the tranche of the PSU grant related to achieving the advertiser count target ("advertiser tranche"). Fifty percent (50%) of the shares subject to the advertiser tranche of the awarded PSU vested upon the Certification, twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 6 months after the Certification, and twenty-five percent (25%) of the shares subject to the advertiser tranche of the awarded PSU will vest 12 months after the Certification, subject to continued service to the Issuer.